Evidence map›Paper›PMID 29619509›Full record

ArticleCancer immunology, immunotherapy : CII2018

Interferon-α2b-induced STAT3 suppression in myeloid-derived suppressor cells in mycosis fungoides.

Larisa J Geskin, Oleg E Akilov, Michael K Schowalter, Louis D Falo

Abstract readLetter
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Larisa J GeskinDepartment of Dermatology, University of Pittsburgh, Pittsburgh, PA, USA.
Oleg E AkilovDepartment of Dermatology, University of Pittsburgh, Pittsburgh, PA, USA.
Michael K SchowalterDepartment of Dermatology, University of Pittsburgh, Pittsburgh, PA, USA.
Louis D FaloDepartment of Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. lof2@pitt.edu.

Funding

Therapuetic Immune Targeting of EphA2 Expressed by Melanoma & Its Tumor-AssociateP50CA121973 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KIRKWOOD, JOHN MUNN · 2008 to 2018
$22.9M
Dendritic Cell Threapy for Cutaneous T-Cell LymphomaR01CA106662 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FALO, LOUIS D · 2005 to 2009
$1.5M
NCI NIH HHS P50 CA121973NCI NIH HHS P50CA121973NCI NIH HHS R01 CA106662
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HumansInterferon-alphaInterferon alpha-2Mycosis FungoidesMyeloid-Derived Suppressor CellsSkin NeoplasmsSTAT3 Transcription FactorInterferon-alphaInterferon alpha-2Interferon-alpha2bSTAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID29619509
PMCPMC8237703

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.